Your session is about to expire
← Back to Search
Anthracycline
Radiotherapy for Hodgkin's Lymphoma
Phase 2
Waitlist Available
Led By Monika Metzger, MD
Research Sponsored by St. Jude Children's Research Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patient is less than or equal to 21 years of age
Patient has a confirmed diagnosis of previously untreated Hodgkin lymphoma
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5.5 (years) median follow-up with minimum 0.3 to maximum 9.4 years follow-up
Awards & highlights
Study Summary
This trial is testing a new treatment for Hodgkin lymphoma to see if it will help patients live disease-free for three years.
Eligible Conditions
- Hodgkin's Lymphoma
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 5.5 (years) median follow-up with minimum 0.3 to maximum 9.4 years follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5.5 (years) median follow-up with minimum 0.3 to maximum 9.4 years follow-up
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
3-year Event-Free Survival Probability
Secondary outcome measures
3-year Event-free Survival (EFS) Probability
3-year Local Failure-free Survival Probability
3-year Overall Survival (OS) Probability
+72 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: All ParticipantsExperimental Treatment10 Interventions
Participants receive 12 weeks of Stanford V chemotherapy which includes Adriamycin®, Vinblastine, Nitrogen Mustard (or Cyclophosphamide), Vincristine, Bleomycin, Etoposide, Prednisone, and G-CSF. After completion of 12 weeks of Stanford V chemotherapy, participants receive radiotherapy.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Prednisone
2014
Completed Phase 4
~2370
Radiotherapy
2017
Completed Phase 3
~2610
Vincristine
2003
Completed Phase 4
~2910
Nitrogen Mustard
2006
Completed Phase 2
~90
Etoposide
2010
Completed Phase 3
~2440
Cyclophosphamide
1995
Completed Phase 3
~3780
G-CSF
2014
Completed Phase 4
~1610
Bleomycin
2001
Completed Phase 3
~4960
Adriamycin®
2006
Completed Phase 2
~90
Vinblastine
1998
Completed Phase 3
~5260
Find a Location
Who is running the clinical trial?
St. Jude Children's Research HospitalLead Sponsor
426 Previous Clinical Trials
5,306,524 Total Patients Enrolled
Monika Metzger, MDPrincipal InvestigatorSt. Jude Children's Research Hospital
3 Previous Clinical Trials
421 Total Patients Enrolled
Jamie Flerlage, MDPrincipal InvestigatorSt. Jude Children's Research Hospital
4 Previous Clinical Trials
488 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger